Adult Podocytopathy, Childhood Primary Nephrotic Syndrome
Conditions
Interventions
Adult podocytopathy:None
Pediatric primary nephrotic syndrome:None
Adult disease control group:None
Healthy children control group:None
Sponsors
Shenzhen Second People's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Adulte, Portosito, Pasipatits (1) Aag>=18 Jes (2) Diano, Sede, Wispri, Marimini, Mar, Chang'e, Disias, Alford, Carl Serge, Mental, Glomerus, Lerosibi, Kidenibio (3) Klinikalmani, Festatión, Bennive, Rotic, Sindrom (Protenuria>=3. 5 grids/24 Ha, Salem Albumin=18 Jes (2) Diano Sede Bikid Nibio Pusi Justi Mari Glomeru Raldi Sisses Osedan Portocito Pasis, Includin: Menbulanos Nephro Pasi (Gate), Igane Fropasi, Lups Nifritis (En), Anka Asochatede Vasculidis, Etz. (3) Wollentari, Patti, Sipatimeon, Anders, Gnaud, Infu, Med, Concente 4. Hirsch Controls (Adurz, Children) (1) Agmalched, Wise, Cols, Pontin, Disia, Sgrup (2) Noshistoli Benkidnidias (3) Nomar, Ulinalysis, Andno, Markidney, Finktien (4) Wollentari, Patti, Sipation, Andes, Gnader, Info, Med, Concent
Exclusion criteria
Exclusion criteria: 1. Secondary MCD or FSGS; 2.Comorbidities such as tumors, SLE, RA, hepatitis B, hepatitis C, HIV and other diseases; 3. Severe active infections; 4. Severely impaired immune response (such as hypogammaglobulinemia, severe reduction in CD4 or CD8 cell counts); 5. Severe heart failure (NYHA class IV); 6. Pregnancy or breastfeeding women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Positive rate of anti-nephrin antibody;Clinical Remission Rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence rate; | — |
Countries
China
Contacts
Public ContactWan Qijun
Shenzhen Second People's Hospital
Outcome results
None listed